摘要
目的:探讨非对比剂增强MRA在肾静脉血管成像当中的应用价值。方法:选取2017年2月~2018年2月某院收治的肾脏肿瘤患者60例作为观察对象,随机分为两组,研究组实施非对比剂增强MRA扫描,参照组实施对比剂增强MRA扫描检查。结果:研究组患者肾静脉图像肿瘤评分在两分以上患者多于参照组,不良反应发生率更低(P<0.05)。结论:非对比剂增强MRA在肾静脉血管成像中的应用价值高。
Objective:To explore the application value of non-contrast media enhanced MRA in renal vein angiography. Methods: 60 patients with renal tumors treated in a hospital from February 2017 to February 2018 were selected as observation objects and randomized. The study group performed non-contrast agent enhanced MRA scans. and the reference group performed contrast agent enhanced MRA scans. Results: The patients with renal vein image tumor scores with more than two points in the study group were more than the reference group. and the incidence of adverse reactions was lower(P<0.05). Conclusion: non-contrast media enhanced MRA has a high application value in renal vein angiography.
引文
1 李晓娟,陈晓,孟晓岩,等.非对比剂增强MRA在肾静脉血管成像中的应用价值.放射学实践,2017,32(1):52~56.
2 成兰,余建明,于群,等.肾动脉流入反转恢复MR血管成像与CT、增强MR血管成像图像质量的比较.中华放射学杂志,2015,49(10):778~782.
3 孙海燕,杨成,袁玉林,等.1.5 T MR肾动脉CeMRA与IFIR的对比分析(附82例报告).临床放射学杂志,2015,34(2):241~244.
4 季敏,吴先胜,龚英,等.并发消化道出血的先天性门体分流畸形8例影像学特征病例系列报告.中国循证儿科杂志,2017,12(5):357~361.
5 汤浩,胡晓萌,王秋霞,等.非对比剂增强磁共振血管成像技术在评估移植肾血管并发症方面的研究.放射学实践,2015,30(5):536~541.
6 杨慧.研究磁共振B-TFE序列非对比剂肾动脉血管成像的临床应用价值.中国保健营养,2017,27(21):406.
7 吴新生,张龙江,唐春香,等.三维对比增强磁共振血管成像诊断肾静脉血栓的价值.医学研究生学报,2013,26(7):721~724.
8 徐贤,安宁豫,李雪,等.老年患者非对比剂增强肾动脉磁共振血管造影的参数优化探讨.中国临床保健杂志,2013,16(3):240~242.